Our results were consistent with previous study indicating that CD47 was regulated by sets of pro-inflammatory super-enhancers in breast cancer, diffuse large B-cell lymphoma and acute lymphoblastic leukemia [40]. The gene discussed is CD47; the disease is breast cancer.